The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning insulin is only released when blood glucose levels are elevated Suppressing glucagon release from pancreatic alpha cells, which reduces hepatic glucose production Slowing gastric emptying , which helps moderate post-meal blood glucose spikes Reducing appetite through central nervous system effects, leading to decreased caloric intake and weight loss Examples of GLP-1 receptor agonists available in the UK include exenatide (Byetta, Bydureon), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity), lixisenatide (Lyxumia), and semaglutide (Ozempic/Rybelsus for diabetes, Wegovy for weight management)
Stopping doesnt mean youve used up your shot
In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and dulaglutide (Trulicity
Warnings and Cautions For laboratory research use only
Compression garments continue to be a mainstay of conservative care and must be properly fit with graduated pressure to assist with symptom control and mobility